Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 251

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 251
---
 cash consideration of $750,000
and a share consideration of 125,000 Class A Ordinary Shares (equivalent to 2,500 Class A Ordinary Shares post Third Reverse Stock Split)
(“Share Consideration”). The Purchase Agreement is filed as Exhibit 10.30 in this registration statement. MicroSort Lab Services,
LLC (“MicroSort”) was incorporated by Genetics & IVF Institute, Inc. in January 2025 to hold all of the Assets (as
defined in the Purchase Agreement) to be transferred to the Company at closing. The Company’s acquisition of MicroSort was completed
on February 28, 2025, and the Share Consideration was issued to GIVF on the same day.

On February 24, 2025, the
Company entered into a Consulting Services Agreement with A SPAC (Holdings) Group Corp (“ASPAC”), pursuant to which the Company
engaged ASPAC for the provision of certain consulting services. It was agreed that the Company would provide consideration in the form
of cash and shares. On March 3, 2025, the Company issued the 150,000 Class A Ordinary Shares to ASPAC (equivalent to 3,000 Class A Ordinary
Shares post Third Reverse Stock Split).

Financial Statement Schedules:

All financial statement schedules
have been omitted because either they are not required, are not applicable or the information required therein is otherwise set forth
in the Company’s financial statements and related notes thereto.

<div align='center'>II-4</div>

Item 8. Exhibits and Financial Statement Schedules

| Exhibit No. 
 1.1         
 3.1         
 4.1         |     | Description                                                                                                                                                                                                                                                                                                                                                       
 Form of Placement Agency Agreement                                                                                                                                                                                                                                                                                                                                
 Amended and Restated Memorandum and Articles of Association of the Company dated July 4, 2025 (incorporated by reference to Exhibit 3.1 of the Company’s Form 6-K filed with the SEC on July 7, 2025)                                                                                                                                                             
 Specimen Class A Ordinary Share Certificate of the Company (incorporated by reference to Exhibit 2.1 of the report on Form 20-F filed with the Securities and Exchange Commission on April 9, 2024)                                                                                                                                                               |
|:------------|:----|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.2         |     | Specimen Warrant Certificate of the Company (incorporated by reference to Exhibit 2.